SLC6A3 and attention deficit-hyperactivity disorder: Dopamine transporter ligands might be useful as substitution or maintenance treatments for psychostimulant abuse [60] or as treatments for attention deficit hyperactivity disorder (ADHD) or even as treatments for depression, for example bupropion.